Research

Area 4

Clinical and experimental neuroimmunology

Research projects
  • Paraneoplasic Disorders of CN S: Autoantigen.

    Principal investigator : Dalmau J.. Funding source: National Institutes of Health (NI H),. Code: NIN DS 9RO1NS077851- 05A2 (previously RO1CA107192).. Average: 04/01/2004 - 07/31/2016

  • Caspr2, lgi-1 and novel antigen autoimmunity in neuropsychiatric dysfunction.

    Principal investigator : Dalmau J.. Funding source: NI MH, Eureka. Code: 1RO1MH094741.. Average: 08/01/2011 - 04/30/2015

  • Treatment of anti-NMDA receptor encephalitis.

    Principal investigator : Dalmau J.. Funding source: NI H Extramural-intramural bedside-to-bench project. Code: . Average: 01/01/2012 - 12/31/2014

  • Immune-mediated disorders of memory, behavior, cognition and psychosis.

    Principal investigator : Dalmau J.. Funding source: Instituto de Salud Carlos III (ISCIII ). Code: PI 11/01780.. Average: 01/01/2012 - 01/01/2012

  • Clinical spectrum and celular and synaptic mechanisms of autoinmune synaptic encephalitides.

    Principal investigator : Dalmau J.. Funding source: Fundació La Marató de TV 3.. Code: 101530. Average: 12/01/2011 - 08/31/2014

  • Clinical and Experimental Neuroimmunology Group.

    Principal investigator : Dalmau J.. Funding source: Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR).. Code: 2014_SGR_93. Average: 01/01/2014 - 12/31/2016

  • Gene Expression Profiling (GEP) of glioblastoma, including long intergenic non-coding RNA (lincRNA ), in a homogeneous population: correlation with immunophenotype, radiology, clinical outcome and response to therapy. A multicenter study.

    Principal investigator : De la Iglesia N.. Funding source: Fundació la Marató de TV 3. Code: 20130331. Average: 05/07/2014 - 05/06/2016

  • Directed Neuronal Differentiation of Glioma Stem-like Initiating Cells.

    Principal investigator : De la Iglesia N.. Funding source: Fundación Ramón Areces.. Code: CIVP 16A1850. Average: 07/01/2012 - 06/30/2015

  • Anticuerpos contra antígenos de membrana neuronal en el síndrome opsoclonus mioclonus.

    Principal investigator : Graus F.. Funding source: Instituto de Salud Carlos III (ISCIII ).. Code: PI 12/00611.. Average: 01/01/2013 - 12/31/2015

  • REEM: Red española de esclerosis múltiple

    Principal investigator : Graus F.. Funding source: Instituto de Salud Carlos III (ISCIII ).. Code: RD07/0060/0012.. Average: 02/29/2008 - 03/04/2014

  • Red Española de Esclerosis Múltiple.

    Principal investigator : Villoslada P.. Funding source: Instituto de Salud Carlos III (ISCIII ).. Code: RD12/0032/0001.. Average: 01/01/2013 - 12/31/2016

  • Mecanismos de daño axonal en neuroinflamación: nuevas estrategias de neuroprotección.

    Principal investigator : Villoslada P.. Funding source: Instituto de Salud Carlos III (ISCIII ).. Code: PI 12/01823.. Average: 01/01/2013 - 12/31/2015

  • A novel drug discovery method based on systems biology: combination therapy and biomarkers for Multiple Sclerosis.

    Principal investigator : Villoslada P.. Funding source: European Commission. Code: 305397. Average: 01/01/2013 - 12/31/2014

  • Red Española de Esclerosis Múltiple.

    Principal investigator : Villoslada P.. Funding source: Instituto de Salud Carlos III (ISCIII ).. Code: RD07/0060/0000. Average: 02/10/2009 - 12/31/2014

  • Desarrollo de terapias neuroprotectoras para Esclerosis Múltiple.

    Principal investigator : Villoslada P.. Funding source: Ministerio de Economía y Competitividad.. Code: IPT -2011-1312-900000. Average: 05/04/2011 - 06/30/2014

  • STOP-ELA : Aproximación multi-tecnológica para el desarrollo de nuevas terapias y sistemas.

    Principal investigator : Villoslada P.. Funding source: Ministerio de Economía y Competitividad.. Code: IPT -2011-1091-900000.. Average: 05/04/2011 - 06/30/2014

  • Tratamiento de la EM y NMO con células dendríticas reguladoras: ensayo clínico fase 1B

    Principal investigator : Villoslada P.. Funding source: FUNDACIÓN GAEM.. Code: 13FC BD70. Average: 01/01/2014 - 12/27/2014